Handel nachbörslich: 1.01 -0.02 -1.94%

Cyclacel Pharmaceuticals Inc (CYCC)

Cyclacel Pharmaceuticals Inc Aktie (CYCC) Neueste Nachrichten

Cyclacel Pharmaceuticals Inc (CYCC)

Cyclacel Pharmaceuticals Inc Aktie (CYCC) Neueste Nachrichten

Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study - ForexTV.com

Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study - StockTitan

Entero Therapeutics (NASDAQ:ENTO) Stock Quotes, Forecast and News Summary - Benzinga

(CYCCP) Trading Report - Stock Traders Daily

Cyclacel Pharmaceuticals (CYCC) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - MSN

Cyclacel Pharmaceuticals (CYCC) Price Target Increased by 11.56% to 13.94 - MSN

Cyclacel halts dividend on preferred stock - Investing.com

Cyclacel halts dividend on preferred stock By Investing.com - Investing.com Canada

Cyclacel halts dividend on preferred stock By Investing.com - Investing.com UK

Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com

Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance UK

Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter - ForexTV.com

Cyclacel Pharmaceuticals May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Benzinga

Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter - StockTitan

Cyclacel Pharmaceuticals Inc (CYCC)’s highs and lows: A closer look at its stock price fluctuations - US Post News

Metric Analysis: Cyclacel Pharmaceuticals Inc (CYCC)’s Key Ratios in the Limelight - The Dwinnex

Cyclacel Pharmaceuticals (CYCC) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance

Cyclacel Pharmaceuticals (CYCC) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Nasdaq

You might want to take a look at Cyclacel Pharmaceuticals Inc (CYCC) now - SETE News

How To Trade (CYCCP) - Stock Traders Daily

Cyclacel Pharmaceuticals faces potential Nasdaq delisting - Investing.com India

Cyclacel Pharmaceuticals faces potential Nasdaq delisting By Investing.com - Investing.com UK

Geopark Ltd, Cyclacel Pharmaceuticals, Another 3 Companies Have A High Estimated Dividend Yield - Via News Agency

Cyclacel stock plunges to 52-week low at $1.13 amid market challenges - Investing.com

Cyclacel stock plunges to 52-week low at $1.13 amid market challenges - Investing.com Canada

Cyclacel stock plunges to 52-week low at $1.13 amid market challenges - Investing.com Australia

Cyclacel stock plunges to 52-week low at $1.13 amid market challenges - Investing.com UK

Cyclacel Pharmaceuticals faces Nasdaq delisting - Investing.com

Cyclacel Pharmaceuticals faces Nasdaq delisting By Investing.com - Investing.com UK

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q2 2024 Earnings Call Transcript - MSN

Cyclacel Pharmaceuticals changes its auditor - Investing.com

Cyclacel Pharmaceuticals changes its auditor By Investing.com - Investing.com UK

Cyclacel stock hits 52-week low at $1.21 amid market challenges - Investing.com

Cyclacel stock hits 52-week low at $1.21 amid market challenges - Investing.com UK

Cyclacel Pharmaceuticals Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Simply Wall St

Cyclacel Pharmaceuticals Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

CYCC’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Ratio Revelations: Cyclacel Pharmaceuticals Inc (CYCC)’s Financial Metrics in the Spotlight - The Dwinnex

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q2 2024 Earnings Call Transcript - Insider Monkey

Earnings call: Cyclacel reports progress in fadraciclib study - Investing.com

Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q2 Loss, Misses Revenue Estimates - MSN

Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update - StockTitan

San Juan Basin Royalty Trust, Cyclacel Pharmaceuticals, Another 4 Companies Have A High Estimated Dividend Yield - Via News Agency

Cyclacel Pharmaceuticals (CYCC) to Release Quarterly Earnings on Wednesday - Defense World

Cyclacel Pharmaceuticals to Release Second Quarter 2024 Financial Results - StockTitan

Cyclacel Pharmaceuticals to Release Second Quarter 2024 Financial Results - Morningstar

Cyclacel Pharmaceuticals, Inc.'s (NASDAQ:CYCC) Path To Profitability - Simply Wall St

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Shares Sold by Acadian Asset Management LLC - Defense World

Cyclacel Pharmaceuticals (CYCC) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance

Cyclacel Pharmaceuticals, Standard Register Company, Another 3 Companies Have A High Estimated Dividend Yield - Via News Agency

(CYCCP) On The My Stocks Page - Stock Traders Daily

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Downgraded by StockNews.com to “Sell” - Defense World

Cyclacel Pharmaceuticals Inc: Rising -85.60% from 52-Week Low, Can the Stock Stay Afloat? - The InvestChronicle

Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions - ForexTV.com

Cyclacel Pharma Shares Rise 11% After European Patent Allowance Notice for Plogosertib - MarketWatch

Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical ... - StockTitan

Cyclacel Pharmaceuticals expands equity incentive plan By Investing.com - Investing.com India

Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions - StockTitan

Kernel Group Holdings amends Business Combination Agreement with AIRO Group By Investing.com - Investing.com

Cyclacel Pharmaceuticals expands equity incentive plan - Investing.com India

Citi lifts Segro stock target, maintains buy stance By Investing.com - Investing.com South Africa

Cyclacel Pharmaceuticals expands equity incentive plan By Investing.com - Investing.com Australia

Cathie Wood's ARK ETF focuses on PagerDuty, 10X Genomics stock By Investing.com - Investing.com

Cyclacel Pharmaceuticals Announces Key Corporate Decisions at 2024 Annual MeetingTipRanks.com - TipRanks

Ähnlich wie CYCC